Webinar Series: The New Challenges Associated with IND Studies – An Industry Perspective

In an industry that is always changing and presenting new challenges, it can be difficult to keep up with everything. The key, however, is being able to plan for, and execute, global investigational new drug (IND) strategies based on specific requirements for certain molecule types and targets, and understanding the FDA’s regulatory procedures.

This webinar series features three unique panel discussions, as industry leaders from pharmaceutical, biotechnology, and Charles River discuss IND strategies, nonhuman targets, and the landscape of drug development during and after COVID-19. Get the expert advice you need to successfully run your current and future IND studies.

drawing of white chalk arrows on blackboard